pulling all prescription and over-the-counter heartburn drugs containing ranitidine from the market on April 1, 2020. GSK ...

Revenue dipped 1.7 percent to £8 billion in the reporting period, a statement added. GSK earlier this month agreed to pay $2.3 billion to end lawsuits alleging that Zantac caused cancer ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Corrects headline to say 'settlements' instead of 'settlement' British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits ...

The “.1” stands for the subwoofer, which usually has its own amplifier built in so your receiver won’t need to provide it with power. Many mid- and higher-priced receivers are labeled as ...

First approved by U.S. regulators in 1983, Zantac became the world's best-selling medicine in 1988 and one of the first to top $1 billion in annual sales. The drug was sold at different times by ...

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was ... results of £1.8 billion ($2.4 billion ...

GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...